PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-May-2022 ADC Therapeutics to Host First Quarter 2022 Financial Results Conference Call on May 9, 2022 Businesswire
03-May-2022 United States Ophthalmic Compounding Pharmacies Industry Report to 2028 - Players Profiled Include Nora Apothecary, Lifecare Pharmacy, Avella Specialty Pharmacy and Triangle Compounding Pharmacy - ResearchAndMarkets.com Businesswire
03-May-2022 Orgenesis Led Consortium awarded EUR 4M European Innovation Council Pathfinder Grant Orgenesis
03-May-2022 Neuraxpharm pursues growth strategy for business in Switzerland Neuraxpharm
03-May-2022 Insights on the Asthma and COPD Drugs Global Market to 2030 - Key Players Include Novartis, Organon and Sanofi - ResearchAndMarkets.com Businesswire
03-May-2022 Global Systemic Scleroderma Treatment Market to 2028 - by Drug Class, Disease Type, Route of Administration, Distribution Channel, and Region - ResearchAndMarkets.com Businesswire
03-May-2022 Bulletin from Moberg Pharma´s Extraordinary General Meeting on 3 May 2022 Moberg Pharma
03-May-2022 New EFSA opinion offers future FSMP application potential for Bimuno® prebiotic ingredient Clasado Biosciences
03-May-2022 JYSELECA®▼ (filgotinib), recommended by the Health Service Executive (HSE) for people with Ulcerative Colitis (UC) in Ireland Galapagos Biotech
03-May-2022 Teva Reports First Quarter 2022 Financial Results Businesswire
03-May-2022 CI Global Asset Management Launches Blockchain and Metaverse ETFs Businesswire
03-May-2022 908 Devices Partners with Key Biomanufacturing Innovation Center Businesswire
03-May-2022 Aura Biosciences to Present at the 2022 Bank of America Healthcare Conference Businesswire
03-May-2022 Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results Businesswire
03-May-2022 Pfizer Reports First-Quarter 2022 Results Businesswire
03-May-2022 Japan In-Vitro Diagnostics (IVD) Market Research Report 2022 - ResearchAndMarkets.com Businesswire
03-May-2022 New Publication Highlights Synergistic Potential of CD37-targeted Radioimmunoconjugate Humalutin® in Combination with the PARP-inhibitor Olaparib Nordic Nanovector
03-May-2022 Solvay launches new growth platform focused on renewable materials and biotechnology Solvay
03-May-2022 MIMETAS Expands Adult Stem Cell Organoid License to All Organs MIMETAS
03-May-2022 Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics Engimmune Therapeutics